2006
DOI: 10.1016/j.biomaterials.2006.08.004
|View full text |Cite
|
Sign up to set email alerts
|

In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
31
0

Year Published

2007
2007
2021
2021

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 72 publications
(31 citation statements)
references
References 18 publications
0
31
0
Order By: Relevance
“…30,31 The nanoparticles were characterized by various methods. As can be seen from the transmission electron microscopic images ( Figure 1A), Cur/SLNs-HU-211 had a spherical shape and uniform size.…”
Section: Characterization Of Nanoparticlesmentioning
confidence: 99%
See 1 more Smart Citation
“…30,31 The nanoparticles were characterized by various methods. As can be seen from the transmission electron microscopic images ( Figure 1A), Cur/SLNs-HU-211 had a spherical shape and uniform size.…”
Section: Characterization Of Nanoparticlesmentioning
confidence: 99%
“…29 Polyoxyethylene (40) stearate (Myrj52), a material used for modifying SLNs, can modulate drug uptake via inhibiting the activity of P-gp. 30,31 In this paper, we aimed to develop and assess SLNs containing Cur and HU-211 (Cur/SLNs-HU-211) for achieving better antidepressant activity. We first synthesized Cur/ SLNs-HU-211 via an emulsification and low-temperature solidification method and examined by means of various apparatus, and then the antidepressant activities of nanoparticles in CORT-induced major depression model were investigated in vitro and in vivo.…”
Section: Introductionmentioning
confidence: 99%
“…There are several papers published, that describe the experimental procedure [43,44]. In brief, the oral dosage form based on the multifunctional polymer is administered either orally or in situ and then drug plasma levels or a therapeutic effect is monitored.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, it has been demonstrated that thiomers can inhibit efflux pumps in vitro (Werle and Hoffer 2006). These findings have been supported by in vivo studies with the efflux pump substrates rhodamine 123 (Fö ger et al 2006a) and saquinavir (Fö ger et al 2006b). One main feature of this class of polymeric inhibitors is their strongly enhanced mucoadhesiveness that would allow a controlled release of paclitaxel at the same intestinal segments as the efflux pump inhibition takes places (BernkopSchnü rch 2004).…”
Section: Introductionmentioning
confidence: 92%